TNGX · Tango Therapeutics Inc.
View on chartInsiders & Stakes
| Third Rock Ventures IV, L.P. 10% Owner | ▼ Sell | Open Market | 13,386,574 Shares held | 10/23/2025 | View profile |
| EcoR1 Capital, LLC 10% Owner | ▼ Sell | Open Market | 10,630,736 Shares held | 11/7/2024 | View profile |
| Boxer Capital, LLC 10% Owner | ▲ Buy | Open Market | 8,198,642 Shares held | 10/16/2023 | View profile |
| Boxer Capital Management, LLC | ▼ Sell | Open Market | 3,610,642 Shares held | 11/6/2024 | View profile |
| Weber Barbara Chief Executive Officer | ▼ Sell | Open Market | 1,629,254 Shares held | 2/3/2026 | View profile |
| Peters Malte Director | ▲ Buy | Grant | 367,500 Shares held | 1/8/2026 | View profile |
| Beckman Daniella Chief Financial Officer | ▼ Sell | Open Market | 184,297 Shares held | 2/3/2026 | View profile |
| Huang Alan Chief Scientific Officer | ▲ Buy | Grant | 167,584 Shares held | 3/1/2023 | View profile |
| Crystal Adam President, R&D | ▼ Sell | Open Market | 115,743 Shares held | 10/1/2026 | View profile |
| MVA Investors, LLC | ▼ Sell | Open Market | 108,793 Shares held | 7/2/2024 | View profile |
| Barry Douglas General Counsel | ▼ Sell | Open Market | 66,014 Shares held | 2/5/2025 | View profile |
| Newcomb Jessica Principal Accounting Officer | ▼ Sell | Open Market | 59,121 Shares held | 9/22/2026 | View profile |
| Rothenberg Mace Director | ▲ Buy | Grant | 41,500 Shares held | 6/5/2026 | View profile |
| Gall Matthew Chief Financial Officer | ▲ Buy | Grant | 40,000 Shares held | 5/1/2026 | View profile |
| Ketchum John B | ▲ Buy | Grant | 24,937 Shares held | 6/5/2026 | View profile |
| Sung Lee EVP, Chief Financial Officer | ▲ Buy | Grant | 22,870 Shares held | 6/5/2026 | View profile |
| Alexis Borisy Director | ▲ Buy | Grant | 17,500 Shares held | 6/5/2025 | View profile |
| Calhoun Lesley Ann Director | ▲ Buy | Grant | 16,500 Shares held | 6/5/2026 | View profile |
| Robert Azelby Director | ▲ Buy | Grant | 5,740 Shares held | 6/19/2026 | View profile |
| Huber Reid M Director | ▲ Buy | Grant | 5,000 Shares held | 6/6/2023 | View profile |
| Davis Aaron I. Director | ▲ Buy | Grant | 5,000 Shares held | 6/6/2023 | View profile |
| Tango Therapeutics, Inc. Director | ▲ Buy | Grant | 3,400 Shares held | 12/8/2021 | View profile |
Transaction History
| Crystal Adam | ▲ Buy | Option Exercise | 27,000 | $140K | 10/1/2026 |
| Crystal Adam | ▼ Sell | Open Market | 26,400 | $646K | 10/1/2026 |
| Crystal Adam | ▼ Sell | Open Market | 600 | $15K | 10/1/2026 |
| Newcomb Jessica | ▼ Sell | Open Market | 700 | $16K | 9/22/2026 |
| Newcomb Jessica | ▼ Sell | Open Market | 5,100 | $122K | 9/22/2026 |
| Newcomb Jessica | ▼ Sell | Open Market | 2,400 | $60K | 9/22/2026 |
| Crystal Adam | ▲ Buy | Option Exercise | 27,000 | $140K | 9/1/2026 |
| Crystal Adam | ▼ Sell | Open Market | 27,000 | $604K | 9/1/2026 |
| Crystal Adam | ▲ Buy | Option Exercise | 27,000 | $140K | 8/3/2026 |
| Crystal Adam | ▼ Sell | Open Market | 5,267 | $141K | 8/3/2026 |
| Crystal Adam | ▼ Sell | Open Market | 21,733 | $594K | 8/3/2026 |
| Crystal Adam | ▲ Buy | Option Exercise | 27,000 | $140K | 7/1/2026 |
| Crystal Adam | ▼ Sell | Open Market | 7,371 | $223K | 7/1/2026 |
| Crystal Adam | ▼ Sell | Open Market | 19,629 | $576K | 7/1/2026 |
| Robert Azelby | ▲ Buy | Grant | 5,740 | $0 | 6/19/2026 |
| Calhoun Lesley Ann | ▲ Buy | Grant | 4,000 | $0 | 6/5/2026 |
| Rothenberg Mace | ▲ Buy | Grant | 4,000 | $0 | 6/5/2026 |
| Ketchum John B | ▲ Buy | Grant | 4,000 | $0 | 6/5/2026 |
| Sung Lee | ▲ Buy | Grant | 570 | $0 | 6/5/2026 |
| Crystal Adam | ▲ Buy | Option Exercise | 27,000 | $140K | 6/1/2026 |
| Crystal Adam | ▼ Sell | Open Market | 6,140 | $137K | 6/1/2026 |
| Crystal Adam | ▼ Sell | Open Market | 20,860 | $481K | 6/1/2026 |
| Crystal Adam | ▲ Buy | Option Exercise | 27,000 | $140K | 5/1/2026 |
| Crystal Adam | ▼ Sell | Open Market | 25,900 | $549K | 5/1/2026 |
| Crystal Adam | ▼ Sell | Open Market | 1,100 | $24K | 5/1/2026 |
| Gall Matthew | ▲ Buy | Grant | 40,000 | $0 | 5/1/2026 |
| Sung Lee | ▲ Buy | Grant | 12,300 | $0 | 4/29/2026 |
| Crystal Adam | ▲ Buy | Option Exercise | 38,460 | $200K | 4/15/2026 |
| Crystal Adam | ▼ Sell | Open Market | 38,460 | $962K | 4/15/2026 |
| Crystal Adam | ▼ Sell | Open Market | 27,000 | $572K | 4/1/2026 |
| Crystal Adam | ▲ Buy | Option Exercise | 27,000 | $140K | 4/1/2026 |
| Crystal Adam | ▲ Buy | Option Exercise | 12,000 | $62K | 3/25/2026 |
| Crystal Adam | ▼ Sell | Open Market | 12,000 | $241K | 3/25/2026 |
| Crystal Adam | ▼ Sell | Open Market | 20,251 | $304K | 3/5/2026 |
| Crystal Adam | ▼ Sell | Open Market | 54,345 | $694K | 2/25/2026 |
| Beckman Daniella | ▼ Sell | Open Market | 10,204 | $125K | 2/3/2026 |
| Beckman Daniella | ▼ Sell | Open Market | 113 | $1K | 2/3/2026 |
| Weber Barbara | ▼ Sell | Open Market | 30,186 | $370K | 2/3/2026 |
| Weber Barbara | ▼ Sell | Open Market | 333 | $4K | 2/3/2026 |
| Crystal Adam | ▼ Sell | Open Market | 18,251 | $224K | 2/3/2026 |
| Crystal Adam | ▼ Sell | Open Market | 201 | $3K | 2/3/2026 |
| Beckman Daniella | ▲ Buy | Grant | 44,330 | $0 | 2/2/2026 |
| Weber Barbara | ▲ Buy | Grant | 37,522 | $0 | 2/2/2026 |
| Crystal Adam | ▲ Buy | Grant | 47,460 | $0 | 2/2/2026 |
| Peters Malte | ▲ Buy | Grant | 350,000 | $0 | 1/8/2026 |
| Sung Lee | ▲ Buy | Grant | 10,000 | $0 | 1/2/2026 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 477,401 | $4.8M | 10/23/2025 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 500,000 | $4.0M | 9/25/2025 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 363,541 | $2.6M | 9/16/2025 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 86,459 | $609K | 9/8/2025 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 642,906 | $4.5M | 9/5/2025 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 302,194 | $2.1M | 8/22/2025 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 1,100,000 | $7.7M | 8/19/2025 |
| Peters Malte | ▲ Buy | Grant | 6,250 | $0 | 6/5/2025 |
| Calhoun Lesley Ann | ▲ Buy | Grant | 6,250 | $0 | 6/5/2025 |
| Rothenberg Mace | ▲ Buy | Grant | 6,250 | $0 | 6/5/2025 |
| Ketchum John B | ▲ Buy | Grant | 6,250 | $0 | 6/5/2025 |
| Alexis Borisy | ▲ Buy | Grant | 6,250 | $0 | 6/5/2025 |
| Barry Douglas | ▼ Sell | Open Market | 2,556 | $8K | 2/5/2025 |
| Beckman Daniella | ▼ Sell | Open Market | 3,948 | $12K | 2/5/2025 |
| Crystal Adam | ▼ Sell | Open Market | 6,851 | $22K | 2/5/2025 |
| Weber Barbara | ▼ Sell | Open Market | 9,013 | $28K | 2/5/2025 |
| Beckman Daniella | ▼ Sell | Open Market | 4,284 | $13K | 2/4/2025 |
| Crystal Adam | ▼ Sell | Open Market | 7,432 | $22K | 2/4/2025 |
| Weber Barbara | ▼ Sell | Open Market | 9,778 | $29K | 2/4/2025 |
| Barry Douglas | ▼ Sell | Open Market | 2,774 | $8K | 2/4/2025 |
| Beckman Daniella | ▲ Buy | Grant | 26,119 | $0 | 2/3/2025 |
| Weber Barbara | ▲ Buy | Grant | 105,875 | $0 | 2/3/2025 |
| Barry Douglas | ▲ Buy | Grant | 27,363 | $0 | 2/3/2025 |
| Crystal Adam | ▲ Buy | Grant | 53,015 | $0 | 2/3/2025 |
| Rothenberg Mace | ▲ Buy | Open Market | 10,000 | $38K | 11/18/2024 |
| Rothenberg Mace | ▲ Buy | Open Market | 10,000 | $36K | 11/14/2024 |
| EcoR1 Capital, LLC | ▼ Sell | Open Market | 62,318 | $205K | 11/7/2024 |
| EcoR1 Capital, LLC | ▼ Sell | Open Market | 1,143,124 | $3.3M | 11/7/2024 |
| EcoR1 Capital, LLC | ▼ Sell | Open Market | 1,494,558 | $4.9M | 11/6/2024 |
| Boxer Capital Management, LLC | ▼ Sell | Open Market | 3,080,000 | $9.7M | 11/6/2024 |
| Boxer Capital Management, LLC | ▼ Sell | Open Market | 633,000 | $4.3M | 10/25/2024 |
| Boxer Capital Management, LLC | ▼ Sell | Open Market | 250,000 | $1.7M | 10/22/2024 |
| Boxer Capital Management, LLC | ▼ Sell | Open Market | 625,000 | $4.4M | 10/21/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 67,400 | $710K | 9/13/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 75,000 | $867K | 9/5/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 175,000 | $2.0M | 8/30/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 25,000 | $289K | 8/27/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 150,000 | $1.5M | 8/19/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 135,000 | $1.3M | 8/16/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 40,000 | $392K | 8/1/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 100,000 | $993K | 7/31/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 95,000 | $931K | 7/30/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 50,000 | $492K | 7/26/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 100,599 | $993K | 7/25/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 200,000 | $2.0M | 7/24/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 125,000 | $1.2M | 7/23/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 262,740 | $2.6M | 7/22/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 191,490 | $1.9M | 7/18/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 550,171 | $5.4M | 7/17/2024 |
| MVA Investors, LLC | ▼ Sell | Open Market | 95,000 | $825K | 7/2/2024 |
| MVA Investors, LLC | ▼ Sell | Open Market | 110,731 | $982K | 7/1/2024 |
| MVA Investors, LLC | ▼ Sell | Open Market | 29,000 | $249K | 6/28/2024 |
| MVA Investors, LLC | ▼ Sell | Open Market | 77,000 | $530K | 6/7/2024 |
| MVA Investors, LLC | ▼ Sell | Open Market | 63,000 | $456K | 6/6/2024 |
| Rothenberg Mace | ▲ Buy | Grant | 6,250 | $0 | 6/5/2024 |
| Calhoun Lesley Ann | ▼ Sell | Open Market | 5,000 | $36K | 6/5/2024 |
| Calhoun Lesley Ann | ▲ Buy | Grant | 6,250 | $0 | 6/5/2024 |
| Ketchum John B | ▲ Buy | Grant | 4,687 | $0 | 6/5/2024 |
| Peters Malte | ▲ Buy | Grant | 6,250 | $0 | 6/5/2024 |
| Alexis Borisy | ▲ Buy | Grant | 6,250 | $0 | 6/5/2024 |
| MVA Investors, LLC | ▼ Sell | Open Market | 60,000 | $457K | 5/3/2024 |
| MVA Investors, LLC | ▼ Sell | Open Market | 75,000 | $567K | 5/2/2024 |
| MVA Investors, LLC | ▼ Sell | Open Market | 75,000 | $557K | 5/1/2024 |
| Third Rock Ventures IV, L.P. | ▼ Sell | Open Market | 162,500 | $1.9M | 2/20/2024 |
| Weber Barbara | ▼ Sell | Open Market | 4,457 | $56K | 2/7/2024 |
| Barry Douglas | ▼ Sell | Open Market | 1,354 | $17K | 2/7/2024 |
| Beckman Daniella | ▼ Sell | Open Market | 1,817 | $23K | 2/7/2024 |
| Crystal Adam | ▼ Sell | Open Market | 4,083 | $52K | 2/7/2024 |
| Weber Barbara | ▼ Sell | Open Market | 4,681 | $59K | 2/6/2024 |
| Barry Douglas | ▼ Sell | Open Market | 1,422 | $18K | 2/6/2024 |
| Beckman Daniella | ▼ Sell | Open Market | 1,908 | $24K | 2/6/2024 |
| Crystal Adam | ▼ Sell | Open Market | 4,288 | $54K | 2/6/2024 |
| Beckman Daniella | ▲ Buy | Grant | 39,413 | $0 | 2/1/2024 |
| Crystal Adam | ▲ Buy | Grant | 46,599 | $0 | 2/1/2024 |
| Weber Barbara | ▲ Buy | Grant | 87,168 | $0 | 2/1/2024 |
| Barry Douglas | ▲ Buy | Grant | 22,859 | $0 | 2/1/2024 |
| Crystal Adam | ▼ Sell | Open Market | 7,507 | $63K | 11/1/2023 |
| Boxer Capital, LLC | ▲ Buy | Open Market | 500,000 | $3.4M | 10/16/2023 |
| Boxer Capital, LLC | ▲ Buy | Open Market | 750,000 | $5.3M | 10/13/2023 |
| Boxer Capital, LLC | ▼ Sell | Open Market | 50,000 | $496K | 10/9/2023 |
| Boxer Capital, LLC | ▼ Sell | Open Market | 175,000 | $1.7M | 10/9/2023 |
| Ketchum John B | ▲ Buy | Grant | 10,000 | $0 | 8/29/2023 |
| Boxer Capital, LLC | ▲ Buy | Open Market | 475,000 | $2.4M | 8/11/2023 |
| Rothenberg Mace | ▲ Buy | Grant | 5,000 | $0 | 6/6/2023 |
| Calhoun Lesley Ann | ▲ Buy | Grant | 5,000 | $0 | 6/6/2023 |
| Alexis Borisy | ▲ Buy | Grant | 5,000 | $0 | 6/6/2023 |
| Huber Reid M | ▲ Buy | Grant | 5,000 | $0 | 6/6/2023 |
| Peters Malte | ▲ Buy | Grant | 5,000 | $0 | 6/6/2023 |
| Davis Aaron I. | ▲ Buy | Grant | 5,000 | $0 | 6/6/2023 |
| Barry Douglas | ▲ Buy | Grant | 23,898 | $0 | 3/1/2023 |
| Huang Alan | ▲ Buy | Grant | 31,697 | $0 | 3/1/2023 |
| Crystal Adam | ▲ Buy | Grant | 81,250 | $0 | 3/1/2023 |
| Weber Barbara | ▲ Buy | Grant | 89,545 | $0 | 3/1/2023 |
| Beckman Daniella | ▲ Buy | Grant | 32,842 | $0 | 3/1/2023 |
| Boxer Capital, LLC | ▲ Buy | Open Market | 70,000 | $325K | 10/13/2022 |
| Boxer Capital, LLC | ▲ Buy | Open Market | 50,000 | $222K | 10/12/2022 |
| Boxer Capital, LLC | ▲ Buy | Open Market | 117,000 | $498K | 10/11/2022 |
| Boxer Capital, LLC | ▲ Buy | Open Market | 70,394 | $286K | 10/6/2022 |
| Boxer Capital, LLC | ▲ Buy | Open Market | 45,500 | $179K | 10/5/2022 |
| Boxer Capital, LLC | ▲ Buy | Open Market | 40,500 | $155K | 10/5/2022 |
| Boxer Capital, LLC | ▲ Buy | Open Market | 25,606 | $94K | 10/4/2022 |
| Tango Therapeutics, Inc. | ▲ Buy | Grant | 3,400 | $0 | 12/8/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Tango Therapeutics to Present Phase 1/2 Vopimetostat Data at ESMO 2026
Tango Therapeutics announced that it will share updated results from its Phase 1/2 study of vopimetostat combined with daraxonrasib or zoldonrasib in patients with MTAP‑deleted/RAS‑mutated metastatic pancreatic cancer and non‑small cell lung cancer at the ESMO Congress 2026. The data focus on a targeted patient group and may provide insight into the early‑stage safety and activity of the combination therapies. The stock is currently near a long‑standing support level, which could be monitored as the conference proceeds.
Tango Therapeutics to Present Phase 1/2 Vopimetostat Data at ESMO 2026. Tango Therapeutics announced that it will share updated results from its Phase 1/2 study of vopimetostat combined with daraxonrasib or zoldonrasib in patients with MTAP‑deleted/RAS‑mutated metastatic pancreatic cancer and non‑small cell lung cancer at the ESMO Congress 2026. The data focus on a targeted patient group and may provide insight into the early‑stage safety and activity of the combination therapies. The stock is currently near a long‑standing support level, which could be monitored as the conference proceeds.